Bosentan Cipla

Medicinal product

(Invented) name

Bosentan Cipla

Active substance (s)

Bozentanas

Strength

125 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C02KX01, Bosentan

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2020-11-04

Date of renewal

Documents

Bosentan_Cipla_paciento kortele (1).pdf

1421-001_Bosentan Cipla_2020-11-04.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Bozentanas	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105207	91308	1091308	lizdinė plokštelė	N56		Receptinis	LT/L/20/1421/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2020-11-04	Registruotas